Lipid Class Composition and Heparin Sensitivity in the Activated Partial Thromboplastin Time

Summary

In an APTT reagent, prepared from purified lipids, the role of phosphatidyl serine (PS) in determining the sensitivity of the APTT test system to measurement of the effect of heparin in plasma has been evaluated. As the concentration of PS decreases sensitivity to heparin increases but procoagulant activity decreases. Dilution of the test liposome over a wide range (1 g/1 to 30 mg/1) had a minimal effect on the clotting time. At levels below 30 mg/1, however, the amount of total lipid appeared to be rate limiting; a loss of procoagulant activity being paralleled by an increase in heparin sensitivity. Phosphatidyl inositol (PI) was not a satisfactory substitute for PS in the APTT method studied. The degree of unsaturation of test liposomes appeared to have no effect on either procoagulant activity or sensitivity to heparin at the lipid concentration employed.

In the light of these findings, a more critical appraisal of the phospholipid components of APTT reagents should facilitate the development of more reliable reagents for heparin control. A further benefit of this type of approach should be a reduction in the acknowledged wide variations in sensitivity to heparin which exist between available APTT reagents.

Keywords

Activated partial thromboplastin time - Heparin - Phosphatidyl serine

• References

• 1 Basu D, Gallus A, Hirsh J, Cade J. A prospective study of the value of monitoring heparin treatment with the activated partial thromboplastin time. N Engl J Med 1972; 287: 324-327
• 2 Shapiro GA, Huntzinger SW, Wilson JE. Variation among commercial activated partial thromboplastin time reagents in response to heparin. Am J Clin Pathol 1977; 67: 477-480
• 3 Poller L, Thomson JM, Yee KF. Heparin and partial thromboplastin time: an international survey. Br J Haematol 1980; 44: 161-165
• 4 Brandt JT, Triplett DA. Laboratory monitoring of heparin. Effect of reagents and instruments on the activated partial thromboplastin time Am J Clin Pathol 1981; 76 Suppl 530-537
• 5 Stevenson KJ, Poller L. The procoagulant activity of partial thromboplastin extracts: the role of phosphatidyl serine. Thromb Res 1982; 26: 341-350
• 6 Petitou M, Tuy F, Rosenfeld C. A simplified procedure for organic phosphorus determination from phospholipids. Anal Biochem 1978; 91: 350-353
• 7 Bitman J, Wood DL, Ruth JM. Two-stage, one dimensional thin layer chromatographic method for separation of lipid classes. J Liquid Chromatog 1981; 4: 1007-1021
• 8 Metcalfe LD, Schmitz AA. The rapid preparation of fatty acid esters for gas chromatographic analysis. Anal Chem 1961; 33: 363-364
• 9 Thomson JM. Blood coagulation and haemostasis: a practical guide. Churchill Livingstone; Edinburgh: 1980
• 10 Slater PJ, Stevenson KJ, Poller L. Procoagulant activity of partial thromboplastin (cephalin) reagent and its phospholipid composition. Thromb Res 1980; 18: 831-838
• 11 Ploplis VA, Castellino FJ. Effect of the biophysical properties of the phospholipid vesicle on the activation of bovine prothrombin. In The regulation of coagulation. Mann KG, Taylor FB. (Eds) Elsevier- North Holland; New York: 1980. pp 121-131
• 12 Tans G, Van Zutphen H, Comfurius P, Hemker HC, Zwaal RF A. Lipid phase transitions and procoagulant activity. Eur J Biochem 1979; 95: 449-157
• 13 Zwaal RF, Comfurius P, Van Deenen LL M. Membrane asymmetry and blood coagulation. Nature 1977; 268: 358-360
• 14 Barrowcliffe TW, Gray E. Studies of phospholipid reagents used in coagulation. II: Factors influencing their sensitivity to heparin. Thromb Haemostas 1981; 46: 634-637